Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of Leukocyte Biology|January 3, 2020
Stimulating pyruvate dehydrogenase complex reduces itaconate levels and enhances TCA cycle anabolic bioenergetics in acutely inflamed monocytesXuewei Zhu, David Long, Manal Zabalawi, et al.Journal of Lipid Research|October 31, 2006
Inflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance?Manal Zabalawi, Manish Bharadwaj, Heather Horton, et al.Journal of Lipid Research|April 3, 2004
Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusionsShaila Bhat, Manal Zabalawi, Mark C Willingham, et al.JCI Insight|June 22, 2022
Dichloroacetate improves systemic energy balance and feeding behavior during sepsisTae Seok Oh, Manal Zabalawi, Shalini Jain, et al.Journal of Leukocyte Biology|July 22, 2022
Sepsis, pyruvate, and mitochondria energy supply chain shortageCharles E McCall, Xuewei Zhu, Manal Zabalawi, et al.International Journal of Molecular Sciences|September 16, 2018
Sirtuins and Immuno-Metabolism of SepsisXianfeng Wang, Nancy L Buechler, Alan G Woodruff, et al.The American Journal of Pathology|August 26, 2003
Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterolManal Zabalawi, Shaila Bhat, Tara Loughlin, et al.Biochimica Et Biophysica Acta|September 28, 2011
Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic miceMary G Sorci-Thomas, Manal Zabalawi, Manish S Bharadwaj, et al.Atherosclerosis|January 25, 2020
Myeloid atg5 deletion impairs n-3 PUFA-mediated atheroprotectionZhan Wang, Russel C Sequeira, Manal Zabalawi, et al.Journal of Lipid Research|January 17, 2015
Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDLHagai Tavori, Yan Ru Su, Patricia G Yancey, et al.Pageof 2